Heidenreich S, Tepel M, Schlüter H, Harrach B, Zidek W
Med. Univ.-Poliklinik, Institut für Arterioskleroseforschung, University of Münster, Germany.
J Clin Invest. 1995 Jun;95(6):2862-7. doi: 10.1172/JCI117992.
The newly recognized human endogenous vasoconstrictive dinucleotides, diadenosine pentaphosphate (AP5A) and diadenosine hexaphosphate (AP6A), were tested for growth stimulatory effects in rat mesangial cells (MC). Both AP5A and AP6A stimulated growth in micromolar concentrations. The growth stimulatory effect exceeded that of ATP, alpha,beta-methylene ATP, adenosine 5'-O-(3-thio)triphosphate and UTP. Both diadenosine phosphates potentiated the growth response to platelet-derived growth factor, but not to insulin-like growth factor-1. To further elucidate the site of action in the cell cycle, RNA and protein synthesis were assessed. AP5 and AP6A stimulated protein synthesis, but not RNA formation. Furthermore, both agents increased cytosolic free Ca2+ concentration. It is concluded that AP5A and AP6A may play a regulatory role in MC growth as progression factors and possibly modify MC proliferation in glomerular disease.
新发现的人类内源性血管收缩性二核苷酸,即五磷酸二腺苷(AP5A)和六磷酸二腺苷(AP6A),在大鼠系膜细胞(MC)中进行了生长刺激作用测试。AP5A和AP6A在微摩尔浓度下均能刺激生长。其生长刺激作用超过了ATP、α,β-亚甲基ATP、腺苷5'-O-(3-硫代)三磷酸和UTP。两种二腺苷磷酸均增强了对血小板衍生生长因子的生长反应,但对胰岛素样生长因子-1没有增强作用。为了进一步阐明在细胞周期中的作用位点,对RNA和蛋白质合成进行了评估。AP5和AP6A刺激蛋白质合成,但不刺激RNA形成。此外,两种物质均增加了胞质游离Ca2+浓度。结论是,AP5A和AP6A可能作为进展因子在系膜细胞生长中起调节作用,并可能改变肾小球疾病中的系膜细胞增殖。